Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 12 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Trevena Inc | TRVN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.409 | 05:13:36 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.409 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 1 | 12 | - | 0.3227 - 3.28 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 07:00:17 | 12 | $ 0.4099 | USD |
Trevena Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 7.51M | 18.32M | - | 3.13M | -40.29M | -2.20 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Trevena News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TRVN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.347 | 0.4199 | 0.3227 | 0.375099 | 184,625 | 0.062 | 17.87% |
| 1 Month | 0.4556 | 0.46 | 0.3227 | 0.3901159 | 389,231 | -0.0466 | -10.23% |
| 3 Months | 0.6195 | 0.70 | 0.3227 | 0.4564529 | 215,468 | -0.2105 | -33.98% |
| 6 Months | 0.55 | 0.7693 | 0.3227 | 0.5167063 | 153,264 | -0.141 | -25.64% |
| 1 Year | 0.625 | 3.28 | 0.3227 | 1.95 | 1,001,406 | -0.216 | -34.56% |
| 3 Years | 43.125 | 55.00 | 0.3227 | 16.85 | 1,131,595 | -42.72 | -99.05% |
| 5 Years | 36.50 | 112.50 | 0.3227 | 40.12 | 1,936,356 | -36.09 | -98.88% |
Trevena Description
| Trevena Inc is an American biotechnology company. The portfolio pipeline is focused on medicines targeting pain management: TRV734: oral medicine for moderate to severe pain; TRV250: oral medicine for migraines; and TRV027: treatment for acute heart failure. Its leading product is oliceridine (TRV130), a protein-based chemical meant to manage moderate to severe acute pain. |
